GO:1901881 positive regulation of protein depolymerization: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901881 (positive regulation of protein depolymerization) is a biological_process term defined as any process that activates or increases the frequency, rate or extent of protein depolymerization [QuickGO].
• Protein depolymerization is the breakdown of protein polymers such as actin filaments, microtubules, and hyaluronan-binding complexes; its positive regulation is essential for cytoskeletal dynamics, cell motility, and extracellular matrix turnover [1,5,8].
• Key molecular players include actin depolymerizing factors (ADF/cofilin), gelsolin, capping protein, and HYBID (KIAA1199), which sever or disassemble protein polymers [3,5,8].
• Dysregulation of positive regulation of protein depolymerization contributes to cancer progression, osteoarthritis, and neurodegenerative disorders [2,6].
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable precise interrogation of genes controlling depolymerization [2,7].
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate research on GO:1901881-related pathways.
Description
Protein depolymerization is the process by which protein polymers are disassembled into their constituent monomers. This process is fundamental to cellular physiology, enabling rapid remodeling of the cytoskeleton, turnover of extracellular matrix components, and regulation of signaling complexes [1,5]. The Gene Ontology term GO:1901881, positive regulation of protein depolymerization, captures any process that activates or increases the frequency, rate, or extent of this depolymerization [QuickGO]. Understanding this regulatory process is critical because it governs dynamic cellular events such as cell migration, division, and organelle homeostasis [1,8]. Research has identified diverse molecular mechanisms that positively regulate protein depolymerization. For example, actin depolymerizing factor (ADF)/cofilin severs actin filaments and promotes subunit dissociation, a process hijacked by pathogens such as HIV-1 to facilitate infection. Similarly, gelsolin and capping protein coordinate the availability of actin filament barbed ends in platelets, directly influencing depolymerization rates. In the extracellular matrix, HYBID (hyaluronan-binding protein involved in hyaluronan depolymerization, KIAA1199) mediates hyaluronan degradation, a process linked to osteoarthritis and cancer [3,6]. Dysregulation of positive regulation of protein depolymerization is implicated in multiple diseases. For instance, TRIM15-mediated Axin1 depolymerization enhances Wnt signaling and promotes colorectal cancer growth. In osteoarthritis, HYBID-mediated hyaluronan depolymerization contributes to synovial inflammation and cartilage degradation. These examples underscore the importance of understanding the regulatory mechanisms and identifying therapeutic targets. This article synthesizes current knowledge on GO:1901881, covering its definition, key genes, research methods, and disease relevance, with a focus on CRISPR-based experimental models.
positive regulation of protein depolymerization At A Glance
| GO ID | GO:1901881 |
|---|---|
| GO term | positive regulation of protein depolymerization |
| Ontology | biological_process |
| Synonym | activation of protein depolymerization; up-regulation of protein depolymerization; positive regulation of protein polymer catabolism |
| Major function | Activates or increases the rate of protein polymer disassembly |
| Related processes | Cytoskeletal dynamics, extracellular matrix turnover, cell motility |
| Key regulators | ADF/cofilin, gelsolin, capping protein, HYBID (KIAA1199), TRIM15 |
| Disease relevance | Cancer, osteoarthritis, neurodegenerative disorders |
What Is GO:1901881?
GO:1901881, positive regulation of protein depolymerization, is a biological process that encompasses any mechanism that activates or increases the frequency, rate, or extent of protein depolymerization. Protein depolymerization itself is the breakdown of a protein polymer into its monomeric subunits. This regulation can occur through direct enzymatic activity, such as severing or depolymerizing enzymes, or through signaling pathways that modify the activity or localization of depolymerization machinery. The term is distinct from negative regulation (GO:1901880) and from protein depolymerization itself (GO:0043241).
Why Is positive regulation of protein depolymerization Important in Cell Biology?
Positive regulation of protein depolymerization is essential for dynamic cellular processes, including cytoskeletal remodeling, cell migration, vesicle trafficking, and extracellular matrix homeostasis [1,5,8]. Its dysregulation is linked to a spectrum of human diseases, from cancer to osteoarthritis, making it a critical area of research for understanding disease mechanisms and developing targeted therapies [2,6].
• Enables rapid actin filament turnover required for cell motility and division [1,8].
• Regulates mitochondrial content mixing and organelle homeostasis through interphase actin waves.
• Controls extracellular matrix remodeling via hyaluronan depolymerization, impacting tissue repair and osteoarthritis [3,6].
• Modulates Wnt signaling through Axin1 depolymerization, influencing colorectal cancer growth.
• Facilitates pathogen entry, as HIV-1 exploits cofilin-mediated actin depolymerization.
• Plays a role in platelet function by regulating actin filament barbed ends.
• Is involved in fenestra formation in endothelial cells via actin-dynamin2 interaction.
• Serves as a potential therapeutic target for cancer, fibrosis, and degenerative diseases [2,6].
What Happens During positive regulation of protein depolymerization?
Initiation by Depolymerizing Enzymes
In simple terms: Special proteins cut or loosen the polymer to start breakdown.
Positive regulation of protein depolymerization often begins with the recruitment or activation of depolymerizing enzymes. For actin filaments, ADF/cofilin binds to filament sides and severs them, creating new ends that accelerate subunit loss. Gelsolin and capping protein coordinate barbed-end dynamics in platelets, where gelsolin severs filaments and capping protein blocks re-elongation, together promoting depolymerization. In the extracellular matrix, HYBID (KIAA1199) acts as a hyaluronan-binding protein that depolymerizes hyaluronan, a large glycosaminoglycan polymer.
Signaling Pathways That Activate Depolymerization
In simple terms: Signals tell the cell when and where to break down polymers.
Extracellular signals, such as growth factors, can trigger positive regulation of protein depolymerization. Epidermal growth factor (EGF) stimulates signaling cascades that modulate actin dynamics. In fibroblasts, growth factor stimulation regulates hyaluronan metabolism, including HYBID-mediated depolymerization. Additionally, TRIM15-mediated ubiquitination of Axin1 leads to its depolymerization, enhancing Wnt signaling in colorectal cancer cells.
Cytoskeletal Remodeling and Organelle Dynamics
In simple terms: Breaking down polymers reshapes the cell and its organelles.
Positive regulation of protein depolymerization is central to cytoskeletal remodeling. An interphase actin wave promotes mitochondrial content mixing and organelle homeostasis, requiring actin depolymerization. In endothelial cells, actin-dynamin2 interaction regulates fenestra formation, a process dependent on actin depolymerization. These examples highlight how depolymerization drives dynamic cellular architecture.
Extracellular Matrix Turnover
In simple terms: Breaking down matrix polymers remodels tissues.
In the extracellular matrix, hyaluronan depolymerization is positively regulated by HYBID (KIAA1199) in synovial fibroblasts, contributing to matrix turnover. This process is implicated in knee osteoarthritis, where excessive hyaluronan degradation leads to joint inflammation and cartilage damage. Thus, positive regulation of protein depolymerization extends beyond intracellular polymers to include extracellular matrix components.
Pathogen Exploitation of Depolymerization
In simple terms: Some pathogens hijack depolymerization to enter cells.
HIV-1 engages cofilin to promote actin depolymerization, facilitating viral entry and intracellular trafficking. This illustrates how positive regulation of protein depolymerization can be subverted by pathogens, making it a target for antiviral strategies.
Key Genes Involved in GO:1901881 positive regulation of protein depolymerization
The following genes and proteins are key players in positive regulation of protein depolymerization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CFL1 (Cofilin-1) | Actin depolymerization factor; severs actin filaments | HIV-1 entry, cytoskeletal dynamics |
| GSN (Gelsolin) | Actin filament severing and capping | Platelet function, actin turnover |
| CAPZA1/CAPZB | Capping protein; blocks barbed ends | Regulates actin polymerization/depolymerization |
| HYBID (KIAA1199) | Hyaluronan depolymerization | Osteoarthritis, cancer [3,6] |
| TRIM15 | E3 ubiquitin ligase; mediates Axin1 depolymerization | Colorectal cancer, Wnt signaling |
| AXIN1 | Scaffold protein; depolymerized by TRIM15 | Wnt signaling, cancer |
| DNM2 (Dynamin2) | Interacts with actin; regulates fenestra formation | Endothelial cell fenestrae |
| ACTB (Beta-actin) | Major actin isoform; polymerizes/depolymerizes | Cytoskeletal dynamics [1,8] |
| ACTG1 (Gamma-actin) | Actin isoform | Cytoskeletal dynamics |
| PFN1 (Profilin-1) | Binds actin monomers; promotes depolymerization | Actin turnover |
| TWF1 (Twinfilin-1) | Actin depolymerization factor | Actin dynamics |
| SSH1 (Slingshot-1) | Phosphatase; activates cofilin | Actin depolymerization |
| LIMK1 | Kinase; inactivates cofilin | Regulates depolymerization |
| ARPC2 | Arp2/3 complex subunit; branches actin | Actin network remodeling |
| WASF1 (WAVE1) | Activates Arp2/3; regulates actin | Cell motility |
| HYAL1 | Hyaluronidase; degrades hyaluronan | Matrix turnover |
| HYAL2 | Hyaluronidase; degrades hyaluronan | Matrix turnover |
| HAS1/2/3 | Hyaluronan synthases; polymerize hyaluronan | Oppose depolymerization |
How Is positive regulation of protein depolymerization Regulated?
Positive regulation of protein depolymerization is controlled by signaling pathways that modulate the activity of depolymerizing enzymes. For actin, cofilin activity is regulated by phosphorylation: LIMK1 phosphorylates and inactivates cofilin, while SSH1 phosphatase reactivates it. Growth factor signaling, such as EGF, can influence these pathways. In the extracellular matrix, HYBID-mediated hyaluronan depolymerization is regulated by growth factors and cytokines. Additionally, TRIM15-mediated ubiquitination of Axin1 triggers its depolymerization, linking ubiquitin signaling to depolymerization regulation.
positive regulation of protein depolymerization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TRIM15 | Colorectal cancer | Knockout in HCT116 cells |
| HYBID (KIAA1199) | Osteoarthritis | Knockdown in synovial fibroblasts |
| CFL1 | HIV-1 infection | Knockout in T cells |
| GSN | Platelet disorders | Knockout in megakaryocytes |
| AXIN1 | Cancer (Wnt signaling) | Point mutation in colorectal cancer cells |
Cancer
Dysregulated positive regulation of protein depolymerization contributes to cancer progression. TRIM15-mediated Axin1 depolymerization enhances Wnt signaling, promoting colorectal cancer growth. HYBID-mediated hyaluronan depolymerization is implicated in tumor invasion and metastasis. Targeting these pathways may offer therapeutic strategies.
Osteoarthritis
In knee osteoarthritis, HYBID (KIAA1199) is a key mediator of hyaluronan depolymerization in synovial fibroblasts, leading to reduced synovial fluid viscosity and joint inflammation. Inhibiting HYBID could be a therapeutic approach.
Neurodegenerative Disorders
Cofilin-mediated actin depolymerization is implicated in neuronal dysfunction, although direct evidence for GO:1901881 in neurodegeneration requires further study. Dysregulation of actin dynamics is a common feature in neurodegenerative diseases.
Viral Infection
HIV-1 exploits cofilin to promote actin depolymerization, facilitating viral entry and spread. Understanding this mechanism may inform antiviral therapies.
From positive regulation of protein depolymerization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate actin depolymerization? | Knockout of gene X in HeLa cells followed by live-cell imaging |
| Does point mutation in gene X affect depolymerization? | CRISPR point mutation knock-in in HEK293T cells |
| Does overexpression of gene X increase depolymerization? | Overexpression in fibroblasts |
| Does tagged gene X localize to depolymerizing polymers? | Knock-in of fluorescent tag in U2OS cells |
| Does gene X regulate hyaluronan depolymerization? | Knockout in synovial fibroblasts |
| Does gene X affect platelet actin dynamics? | Knockout in platelet-like cells |
How to Study the positive regulation of protein depolymerization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell imaging | Real-time depolymerization dynamics | Actin wave analysis |
| In vitro depolymerization assay | Rate of polymer disassembly | Cofilin activity |
| Phospho-proteomics | Phosphorylation of depolymerization regulators | LIMK1/SSH1 signaling |
| CRISPR knockout screen | Genes affecting depolymerization | Identify novel regulators |
| Co-immunoprecipitation | Protein-protein interactions | TRIM15-Axin1 interaction |
| Hyaluronan degradation assay | Hyaluronan depolymerization | HYBID activity |
| Platelet actin assay | Barbed-end dynamics | Gelsolin/capping protein function |
Live-Cell Imaging
Live-cell imaging using fluorescently tagged actin or microtubule probes allows real-time visualization of depolymerization dynamics. For example, actin wave formation and mitochondrial content mixing can be tracked. This method is ideal for studying positive regulation of protein depolymerization in response to stimuli.
Biochemical Depolymerization Assays
In vitro depolymerization assays using purified proteins (e.g., actin, cofilin, gelsolin) measure the rate of polymer disassembly via fluorescence or sedimentation [5,8]. These assays help identify direct regulators and quantify their effects.
Proteomics and Interactomics
Mass spectrometry-based proteomics can identify proteins associated with depolymerizing polymers and post-translational modifications that regulate depolymerization. Proximity labeling or co-immunoprecipitation can reveal interaction partners.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that positively regulate protein depolymerization. For example, a screen for regulators of actin depolymerization could use a fluorescent reporter of filament disassembly [1,2].
How CRISPR Can Be Used to Study GO:1901881 positive regulation of protein depolymerization
Knockout
CRISPR knockout of genes such as TRIM15 or HYBID can abolish their depolymerization activity, allowing researchers to assess their contribution to processes like Wnt signaling or hyaluronan turnover [2,6]. Knockout models are essential for loss-of-function studies.
Point Mutation
Introducing point mutations in genes like AXIN1 can disrupt specific phosphorylation or ubiquitination sites, revealing how post-translational modifications regulate depolymerization. This approach provides mechanistic insights.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into genes such as DNM2 enables real-time tracking of protein localization during depolymerization events. Tagged knock-ins are valuable for imaging studies.
Overexpression
Overexpression of depolymerization factors like cofilin or HYBID can enhance depolymerization rates, mimicking disease states or testing gain-of-function hypotheses [3,5]. This is useful for identifying downstream effects.
How EDITGENE Supports positive regulation of protein depolymerization Research
Researchers studying positive regulation of protein depolymerization-related genes often need to determine whether a candidate gene is causally involved in depolymerization or is merely correlated. CRISPR-based models provide the gold standard for establishing causality, and EDITGENE offers a comprehensive suite of services to generate such models efficiently.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein depolymerization research.
Frequently Asked Questions About positive regulation of protein depolymerization
What is GO:1901881?
GO:1901881 is the Gene Ontology term for positive regulation of protein depolymerization, defined as any process that activates or increases the frequency, rate or extent of protein depolymerization [QuickGO].
What genes are involved in positive regulation of protein depolymerization?
Key genes include CFL1 (cofilin), GSN (gelsolin), HYBID (KIAA1199), TRIM15, and AXIN1, among others [2,3,5,6,8].
How is protein depolymerization regulated?
It is regulated by signaling pathways that modify depolymerizing enzymes, such as LIMK1/SSH1-mediated phosphorylation of cofilin, and by ubiquitination of substrates like Axin1 [2,5].
What diseases are associated with dysregulated protein depolymerization?
Cancer, osteoarthritis, and viral infections are linked to altered depolymerization [2,5,6].
What methods are used to study positive regulation of protein depolymerization?
Live-cell imaging, in vitro depolymerization assays, proteomics, and CRISPR screens are commonly used [1,2,5,8].
How can CRISPR be used to study GO:1901881?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of genes controlling depolymerization [2,7].
What is the role of cofilin in depolymerization?
Cofilin severs actin filaments and promotes subunit dissociation, positively regulating depolymerization.
How does HYBID contribute to osteoarthritis?
HYBID mediates hyaluronan depolymerization in synovial fibroblasts, leading to joint inflammation and cartilage degradation.
Can protein depolymerization be targeted therapeutically?
Yes, inhibiting depolymerization factors like TRIM15 or HYBID is being explored for cancer and osteoarthritis [2,6].
What services does EDITGENE offer for depolymerization research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services [2,7].
Conclusion
Positive regulation of protein depolymerization (GO:1901881) is a fundamental biological process that controls cytoskeletal dynamics, extracellular matrix turnover, and cellular signaling. Its dysregulation is implicated in cancer, osteoarthritis, and infectious diseases, making it a promising therapeutic target. Advances in CRISPR-based models and imaging technologies continue to unravel the molecular mechanisms, offering new opportunities for drug discovery. EDITGENE's comprehensive services support researchers in dissecting these pathways with precision.
References
- 1. Coscia SM et al.. 2024. An interphase actin wave promotes mitochondrial content mixing and organelle homeostasis.. Nat Commun 15(1):3793 PMID: 38714822
- 2. Liang H et al.. 2025. Targeting TRIM15-mediated Axin1 depolymerization suppresses Wnt signaling and inhibits colorectal cancer growth.. Cell Death Dis 17(1):152 PMID: 41461634
- 3. Nagaoka A et al.. 2015. Regulation of Hyaluronan (HA) Metabolism Mediated by HYBID (Hyaluronan-binding Protein Involved in HA Depolymerization, KIAA1199) and HA Synthases in Growth Factor-stimulated Fibroblasts.. J Biol Chem 290(52):30910-23 PMID: 26518873
- 4. Boonstra J et al.. 1995. The epidermal growth factor.. Cell Biol Int 19(5):413-30 PMID: 7640657
- 5. Bukrinsky M. 2008. How to engage Cofilin.. Retrovirology 5:85 PMID: 18808680
- 6. Shiozawa J et al.. 2020. Implication of HYBID (Hyaluronan-Binding Protein Involved in Hyaluronan Depolymerization) in Hyaluronan Degradation by Synovial Fibroblasts in Patients with Knee Osteoarthritis.. Am J Pathol 190(5):1046-1058 PMID: 32084364
- 7. Nakakura T et al.. 2022. Regulation of fenestra formation via actin-dynamin2 interaction in rat pituitary endothelial cells.. Cell Tissue Res 390(3):441-451 PMID: 36102975
- 8. Barkalow K et al.. 1996. Coordinated regulation of platelet actin filament barbed ends by gelsolin and capping protein.. J Cell Biol 134(2):389-99 PMID: 8707824
